<DOC>
	<DOCNO>NCT01118221</DOCNO>
	<brief_summary>The incidence prevalence IPF increase exponentially age , IPF occur often old male . Cigarette smoke environmental dust exposure know risk factor develop IPF . For example , recently deploy military population , age , especially increase risk IPF . No effective therapy exist , although lung transplantation use extend survival select patient . Defining specific therapy improve exercise tolerance dyspnea IPF patient thus urgent priority veteran-oriented research program .</brief_summary>
	<brief_title>Rehabilitation Idiopathic Pulmonary Fibrosis ( IPF ) Patients</brief_title>
	<detailed_description>Chronic lung disease common veteran population . While chronic obstructive pulmonary disease ( COPD ) prominent , fibrotic lung disease , typify idiopathic pulmonary fibrosis ( IPF ) , clearly increase . We develop extensive experience VA idiopathic pulmonary fibrosis ( IPF ) population context randomize , control clinical trial vasodilator therapy . Based current literature preliminary experience exercise test IPF patient , hypothesize : 1 . Formal pulmonary rehabilitation ( i.e. , aerobic exercise program ) result improve outcome IPF patient , demonstrable : 1 . Increase exercise tolerance quantify 6-minute walk test ( MWT ) distance ; 2 . Decrease post-exercise dyspnea quantify Borg dyspnea scale ; 3 . Overall subjective improvement quality life quantify Saint George 's Respiratory Questionnaire . 2 . Metabolic physiologic mechanism improve exercise tolerance decrease dyspnea include : 1 . More efficient oxygen metabolism demonstrate maximum O2 uptake ( VO2max ) ; 2 . Decreased post-exercise oxidant stress demonstrate post-exercise isoprostanes plasma total antioxidant capacity ( TAC ) ; , 3 . Maintenance maximum inspiratory expiratory pressure ( PInmax PExmax ) . Our Specific Objectives : 1 . To investigate formal pulmonary rehabilitation exercise tolerance IPF patient The following important endpoint assess test work hypothesis pulmonary rehabilitation improve exercise capacity lessen dyspnea : 1 . 6-MWT distance ; 2 . Dyspnea index ; , 3 . Quality life ( Saint George 's Respiratory Questionnaire [ SGRQ ] International Physical Activity Questionnaire [ IPAQ ] ) . 2 . To assess change oxygen uptake , marker oxidant stress pulmonary function result pulmonary rehabilitation To test work hypothesis improve outcomes associate efficient O2 utilization , decrease marker oxidant stress maintain effort dependent pulmonary function , follow variable measure : 1 . Peak oxygen uptake ( VO2peak ) constant load exercise ; 2 . Markers oxidant stress , include plasma urine isoprostanes ; , 3 . Maximum inspiratory expiratory pressure ( PInmax PExmax ) . Completion Specific Objectives position research group conduct future study 1 ) mechanism exercise limitation 2 ) antioxidant therapy , define population risk develop pulmonary fibrosis . The long term impact application thus develop effective pulmonary rehabilitation strategy IPF patient , base knowledge underlie change oxygen metabolism oxidant stress .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Clinical presentation consistent IPF onset three month 48 month prior screen . Diagnosis make highresolution compute tomographic scan show highly probable IPF . Absence severe pulmonary hypertension ( i.e. , PAsys must less 55 mm Hg , base echocardiography ) absence decompensated right heart failure ( NYHA class I II acceptable ) . Age 40 80 , inclusive . Abnormal pulmonary function test ( FVC 4090 % predict DLCO 3090 % predict impaired gas exchange rest exercise ) . Sixminute walk distance 150 500 m. Worsening demonstrate one follow within past year : &gt; 10 % decrease percent predict forced vital capacity worsen dyspnea rest upon exertion , base history . Ability understand sign write informed consent form comply requirement study . Absence clinical feature suggest infection , neoplasm , sarcoidosis collagenvascular disease . Echocardiographic evidence severe pulmonary hypertension ( PAsys &gt; 55 mm Hg , base echocardiography TR velocity 3.2 m/sec ) . Severe heart failure ( NYHA class III IV LVEF &lt; 45 % ) . Sixminute walk distance &lt; 150 &gt; 500 m. FEV1/FVC ratio &lt; 0.7 screening ( postbronchodilator ) . Residual volume &gt; 100 % predict . Any condition IPF likely result death participant within next two year . History unstable deteriorate cardiac neurologic disease . Pregnancy lactation . Patients : ( ) pregnant ( b ) breast feeding exclude study . Current treatment corticosteroid ( either oral inhale ) , Cytoxan , azathioprine , colchicine , pirfenidone , antitumor necrosis factor therapy endothelin receptor blocker . Prior treatment permit , least four week treatment washout prior inclusion study require . Investigational therapy indication within 28 day prior enrollment . Degenerative arthritis , cerebrovascular accident limitation mobility prevent completion 6minute walk test . Oxygen saturation room air &lt; 80 % rest .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>oxidant stress</keyword>
	<keyword>exercise</keyword>
</DOC>